Acute arterial thrombosis in a colon cancer patient after administration of oxaliplatin with capecitabine chemotherapy “case report”

Colorectal cancer is increasing around the world, with many treatment modalities are used in the management of this disease, including surgery, radiotherapy and systemic therapy. The most common chemotherapy agents used in the treatment of colorectal cancer are 5-Fluourouracil (5-FU), Capecitabine,...

Full description

Bibliographic Details
Main Authors: Tala Alawabdeh, Riyad T. Ellati, Rula Amarin, Walid Masoud, Ramiz Abuhijlih
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Current Problems in Cancer: Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666621922000308
Description
Summary:Colorectal cancer is increasing around the world, with many treatment modalities are used in the management of this disease, including surgery, radiotherapy and systemic therapy. The most common chemotherapy agents used in the treatment of colorectal cancer are 5-Fluourouracil (5-FU), Capecitabine, Oxaliplatin and Irinotecan. In this report, we describe a case of 56-year-old female with colorectal cancer and liver metastases who presented with intestinal obstruction and underwent urgent surgery, eight weeks after the surgery she started on chemotherapy XELOX (Capecitabine and Oxaliplatin), 10 days of the first cycle of chemotherapy she presented to emergency room with acrocyanosis, pain and paresthesia in her left hand. She had bluish discoloration of her fourth and fifth left digits, with absent ulnar and radial pulses, Doppler US revealed absence of blood flow. Urgent arterial thrombectomy performed. Then Oxaliplatin was omitted and patient continued her treatment without major sequela. This report demonstrates arterial thrombosis as a rare but serious complication that can occur with the use of Oxaliplatin in addition to Capecitabine.
ISSN:2666-6219